All In Biotech

Drug Trial Radar · NCT06397911

Evaluate Efficacy and Safety of Repeat Subcutaneous Doses of FB825 in Adults With Moderate-to-Severe Atopic Dermatitis

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy, Pharmacokinetics, and Safety of Repeat Subcutaneous Doses of FB825 in Adults With Moderate-to-Severe Atopic Dermatitis

Last checked: Nov 19, 2026Latest source record: Jun 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 114 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

114

Planned (sponsor's estimate)

Start

Aug 8, 2024

Primary completion

May 31, 2027

Study completion May 31, 2027

Sponsor

Lead sponsor
Oneness Biotech Co., Ltd.Industry
Sponsor type
Industry
First posted
May 3, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a randomized, placebo-controlled and double-blind study to evaluate the efficacy, pharmacokinetics, and Safety of repeat subcutaneous doses of FB825 in adults with moderate-to-severe atopic dermatitis.

Conditions

  • Atopic Dermatitis

Interventions

  • FB825Drug

    The study treatment will be administered as 5 SC doses in total 12 weeks

  • PlaceboDrug

    The study treatment will be administered as 5 SC doses in total 12 weeks

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The percentage change from baseline in Eczema Area and Severity Index (EASI) scoreTime frame: Week 16

Locations

16 sites in 2 countries. Site status is shown where the registry gives one.

  • First OC Dermatology

    Fountain Valley, California · Recruiting

  • Center for Dermatology Clinical Research, Inc.

    Fremont, California · Recruiting

  • California Allergy and Asthma Medical Group

    Los Angeles, California · Recruiting

  • University of California, Davis Health, Department of Dermatology

    Sacramento, California · Recruiting

  • UT Health Science Houston

    Bellaire, Texas · Recruiting

  • Center for Clinical Studies

    Webster, Texas · Recruiting

  • Kaohsiung Chang Gung Memorial Hospital

    Kaohsiung City, Taiwan · Recruiting

  • Kaohsiung Veterans General Hospital

    Kaohsiung City, Taiwan · Recruiting

  • Linkou Chang Gung Memorial Hospital

    New Taipei City, Taiwan · Recruiting

  • Taipei Medical University-Shuang Ho Hospital

    New Taipei City, Taiwan · Recruiting

  • China Medical University Hospital

    Taichung, Taiwan · Recruiting

  • National Cheng Kung University Hospital

    Tainan, Taiwan · Recruiting

  • National Taiwan University Hospital

    Taipei, Taiwan · Recruiting

  • Taipei Mackay Memorial Hospital

    Taipei, Taiwan · Recruiting

  • Taipei Veterans General Hospital

    Taipei, Taiwan · Recruiting

  • Tri-Service General Hospital

    Taipei, Taiwan · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.